A Randomised Controlled Crossover Pilot Study of Meropenem Standard 30 Minute Infusion Versus Prolonged 3 Hour Infusion in Intensive Care Patients

Trial Profile

A Randomised Controlled Crossover Pilot Study of Meropenem Standard 30 Minute Infusion Versus Prolonged 3 Hour Infusion in Intensive Care Patients

Completed
Phase of Trial: Phase IV

Latest Information Update: 08 Jun 2016

At a glance

  • Drugs Meropenem (Primary)
  • Indications Bacterial infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 Jul 2012 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
    • 15 Mar 2012 Status changed from recruiting to completed as reported by Australian New Zealand Clinical Trials Registry.
    • 15 Mar 2012 New source identified and integrated (Australian New Zealand Clinical Trials Registry; ACTRN12612000284864).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top